Trial
NCT00670397
Photodynamic Therapy Using HPPH in Treating Patients With Recurrent Dysplasia, Carcinoma in Situ, or Stage I Oral Cavity Cancer
Phase ITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Roswell Park Cancer Institute
Collaborators
—
Condition
Head and Neck Cancer
Intervention
HPPH
Why stopped
safety issues
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-03-16